文献
J-GLOBAL ID:201202286812515134
整理番号:12A1651935
関節リウマチ患者に対するインターロイキン-12/インターロイキン-23阻害剤であるApilimod Mesylateの第IIa相,無作為化,二重盲検,プラセボ対照試験
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of Apilimod Mesylate, an Interleukin-12/Interleukin-23 Inhibitor, in Patients With Rheumatoid Arthritis
著者 (12件):
KRAUSZ Sarah
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
BOUMANS Maria J. H.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
GERLAG Danielle M.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
LUFKIN Joelle
(Synta Pharmaceuticals, Massachusetts)
,
VAN KUIJK Arno W. R.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
BAKKER Alian
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
DE BOER Maarten
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
LODDE Beatrijs M.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
REEDQUIST Kris A.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
,
JACOBSON Eric W.
(Synta Pharmaceuticals, Massachusetts)
,
O’MEARA Michael
(Synta Pharmaceuticals, Massachusetts)
,
TAK Paul P.
(Academic Medical Center/Univ. of Amsterdam, Amsterdam, NLD)
資料名:
Arthritis & Rheumatism
(Arthritis & Rheumatism)
巻:
64
号:
6
ページ:
1750-1755
発行年:
2012年06月
JST資料番号:
C0784B
ISSN:
0004-3591
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)